{
  "abstract": "We read with interest the multicentre study by Guo et al, which developed a late-fusion imaging model (LFM) and a clinical-radiological model (CRM) for hepatocellular carcinoma treated with transarterial chemoembolisation (TACE).1 The multinational cohort, the external validation in Warsaw and the radiogenomic analyses are important strengths. However, several aspects of the manuscript’s clinical interpretation would benefit from clearer definition.",
  "authors": [
    {
      "affiliations": [
        "Department of Gastroenterology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, People's Republic of China",
        "Guangxi Medical University, Nanning, Guangxi, People's Republic of China"
      ],
      "name": "Shuang Shen"
    },
    {
      "affiliations": [
        "Guangxi Medical University, Nanning, Guangxi, People's Republic of China"
      ],
      "name": "Guodong Yang"
    },
    {
      "affiliations": [
        "Department of Gastroenterology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, People's Republic of China"
      ],
      "name": "Xin Qiu"
    }
  ],
  "title": "Clarifying the clinical role and implementation boundaries of the clinical-radiological model for TACE-treated hepatocellular carcinoma",
  "uid": "36b0663a-7bb2-5ba1-8ef5-5c9075c37d13"
}